Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: a post hoc analysis of the randomized TERIKIDS trial

J Kuhle, T Chitnis, B Banwell… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Background: The phase 3 TERIKIDS study demonstrated efficacy and manageable safety for
teriflunomide versus placebo in children with relapsing multiple sclerosis (RMS). Objective …
被引用次数：9 相关文章

Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial.

J Kuhle, T Chitnis, B Banwell, M Tardieu… - Multiple Sclerosis …, 2023 - europepmc.org
Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or
placebo: A post hoc analysis of the randomized TERIKIDS trial. - Abstract - Europe PMC Sign in …

Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial.

J Kuhle, T Chitnis, B Banwell… - Multiple Sclerosis …, 2023 - search.ebscohost.com
Background: The phase 3 TERIKIDS study demonstrated efficacy and manageable safety for
teriflunomide versus placebo in children with relapsing multiple sclerosis (RMS). Objective …
[HTML] nih.gov

[HTML][HTML] Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial

J Kuhle, T Chitnis, B Banwell, M Tardieu… - Multiple Sclerosis …, 2023 - ncbi.nlm.nih.gov
Background: The phase 3 TERIKIDS study demonstrated efficacy and manageable safety for
teriflunomide versus placebo in children with relapsing multiple sclerosis (RMS). Objective …

Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial

J Kuhle, T Chitnis, B Banwell, M Tardieu, DL Arnold… - 2023 - pubmed.ncbi.nlm.nih.gov
Background The phase 3 TERIKIDS study demonstrated efficacy and manageable safety for
teriflunomide versus placebo in children with relapsing multiple sclerosis (RMS). Objective …

Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial.

J Kuhle, T Chitnis, B Banwell, M Tardieu… - Multiple Sclerosis …, 2023 - europepmc.org
Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or
placebo: A post hoc analysis of the randomized TERIKIDS trial. - Abstract - Europe PMC Sign in …